AstraZeneca
novel fixed dose combinations and with opportunity to enhance efficacy | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
39 of 86
Related slides by other companies
Ocuphire Pharma
Investor Presentation
August 2023
preclinical data oral blocks | Ocuphire Pharma
Recursion Pharmaceuticals
Investor Day
January 2023
clinical efficacy found in in mice models led to significant progression free survival further confidence preclinical studies confirming insight | Recursion Pharmaceuticals
OKYO Pharma
Results
June 2023
validation efficacy in dry eye mouse model | OKYO Pharma
Ocuphire Pharma
Investor Presentation
November 2023
preclinical data oral blocks | Ocuphire Pharma
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights